Jacobio Pharmaceuticals CEO on Hong Kong IPO, Biotech

The video discusses a pharmaceutical company's IPO, focusing on new drug development for cancer treatment. It highlights future plans for clinical trials in the US and China, partnerships with companies like AbbVie, and revenue strategies through licensing. The company aims to expand globally, overcoming regulatory challenges by aligning with US FDA standards. The discussion also covers investor sentiment and market strategies for biotech companies.

What are the main concerns regarding the performance of pharmaceutical companies after going public?

What is the focus of the new project mentioned in the text?

How does the company plan to utilize the funds raised from the IPO?

What is the significance of partnerships with larger pharmaceutical companies?

What is the company's outlook for generating revenue in the coming years?

How does the company differentiate itself from other pharmaceutical companies in the market?

What challenges does the company anticipate in regulatory processes outside of China?